Analysis of differential gene expression by fiber-optic BeadArray and pathway in prolactinomas

Endocrine

Volumn 38, Issue 3, 2010, Pages 360-368

  Jiang, Zhiquan ^a   Gui, Songbo ^b   Zhang, Yazhuo ^c  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Fiber optic BeadArray; Gene expression profiling; Pathway analysis; Pituitary adenomas; Prolactinomas

Indexed keywords

15 HYDROXYPROSTAGLANDIN DEHYDROGENASE; ANGIOPOIETIN 2; CALGRANULIN B; GONADORELIN; HIG1 DOMAIN FAMILY MEMBER 1B PROTEIN; INTERLEUKIN 8; PROTEIN P53; SUPPRESSION OF TUMORIGENICITY 18 PROTEIN; TUMOR PROTEIN; UNCLASSIFIED DRUG; WNT INHIBITORY FACTOR 1 PROTEIN;

ADULT; ARTICLE; BIOINFORMATICS; CARCINOGENESIS; CONTROLLED STUDY; DOWN REGULATION; EXPRESSED SEQUENCE TAG; FEMALE; FIBER OPTICS; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; HUMAN; HUMAN TISSUE; MALE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROLACTINOMA; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 79951676216     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-010-9389-2     Document Type: Article

References (47)

1. R. Krysiak, B. Okopien, B. Marek, W. Szkrobka, Prolactinoma. Przegl. Lek. 66(4), 198-205 (2009)
2. S.L. Asa, S. Ezzat, The pathogenesis of pituitary tumours. Nat. Rev. Cancer 2(11), 836-849 (2002) (Pubitemid 37328902)
3. S.L. Asa, S. Ezzat, The cytogenesis and pathogenesis of pituitary adenomas. Endocr. Rev. 19(6), 798-827 (1998) (Pubitemid 128506522)
4. V. Herman, J. Fagin, R. Gonsky, K. Kovacs, S. Melmed, Clonal origin of pituitary adenomas. J. Clin. Endocrinol. Metab. 71(6), 1427-1433 (1990) (Pubitemid 120032755)
5. J.M. Alexander, B.M. Biller, H. Bikkal, N.T. Zervas, A. Arnold, A. Klibanski, Clinically nonfunctioning pituitary tumors are monoclonal in origin. J. Clin. Invest. 86(1), 336-340 (1990) (Pubitemid 20227010)
6. A. Spada, G. Mantovani, A. Lania, Pathogenesis of prolactinomas. Pituitary 8(1), 7-15 (2005) (Pubitemid 44680080)
7. S. Mao, G. Dong, Discovery of highly differentiative gene groups from microarray gene expression data using the gene club approach. J. Bioinform. Comput. Biol. 3(6), 1263-1280 (2005) (Pubitemid 43119049)
8. C.O. Evans, A.N. Young, M.R. Brown, D.J. Brat, J.S. Parks, A.S. Neish, N.M. Oyesiku, Novel patterns of gene expression in pituitary adenomas identified by complementary deoxyribonucleic acid microarrays and quantitative reverse transcriptionpolymerase chain reaction. J. Clin. Endocrinol. Metab. 86(7), 3097-3107 (2001) (Pubitemid 32673472)
9. D.G. Morris, M. Musat, S. Czirjak, Z. Hanzely, D.M. Lillington, M. Korbonits, A.B. Grossman, Differential gene expression in pituitary adenomas by oligonucleotide array analysis. Eur. J. Endocrinol. 153(1), 143-151 (2005) (Pubitemid 41030525)
10. C.O. Evans, C.S. Moreno, X. Zhan, M.T. McCabe, P.M. Vertino, D.M. Desiderio, N.M. Oyesiku, Molecular pathogenesis of human prolactinomas identified by gene expression profiling, RTqPCR, and proteomic analyses. Pituitary 11(3), 231-245 (2008)
11. Livak K.J., Schmittgen T.D., Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25(4), 402-408 (2001) (Pubitemid 34164012)
12. N. Denko, C. Schindler, A. Koong, K. Laderoute, C. Green, Giaccia A. Epigenetic regulation of gene expression in cervical cancer cells by the tumor microenvironment. Clin. Cancer Res. 6(2), 480-487 (2000) (Pubitemid 30111467)
13. F. Shibata, K. Miyama, F. Shinoda, J. Mizumoto, K. Takano, H. Nakagawa, Fibroblast growth-stimulating activity of S100A9 (MRP-14). Eur. J. Biochem. 271(11), 2137-2143 (2004) (Pubitemid 38747983)
14. I. Marenholz, Heizmann C.W., G. Fritz, S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature). Biochem. Biophys. Res. Commun. 322(4), 1111-1122 (2004) (Pubitemid 39164640)
15. K. Arai, T. Yamada, R. Nozawa, Immunohistochemical investigation of migration inhibitory factor-related protein (MRP)-14 expression in hepatocellular carcinoma. Med. Oncol. 17(3), 183-188 (2000) (Pubitemid 30655739)
16. K. Arai, T. Teratani, R. Nozawa, T. Yamada, Immunohistochemical investigation of S100A9 expression in pulmonary adenocarcinoma: S100A9 expression is associated with tumor differentiation. Oncol. Rep. 8(3), 591-596 (2001) (Pubitemid 33758460)
17. K. Arai, T. Teratani, R. Kuruto-Niwa, T. Yamada, R. Nozawa, S100A9 expression in invasive ductal carcinoma of the breast: S100A9 expression in adenocarcinoma is closely associated with poor tumour differentiation. Eur. J. Cancer 40(8), 1179-1187 (2004) (Pubitemid 38526336)
18. A. Hermani, J. Hess, B. de Servi, S. Medunjanin, R. Grobholz, L. Trojan, P. Angel, D. Mayer, Calcium-binding proteins S100A8 and S100A9 as novel diagnostic markers in human prostate cancer. Clin. Cancer Res. 11(14), 5146-5152 (2005) (Pubitemid 41003699)
19. K. Arai, S. Takano, T. Teratani, Y. Ito, T. Yamada, R. Nozawa, S100A8 and S100A9 overexpression is associated with poor pathological parameters in invasive ductal carcinoma of the breast. Curr. Cancer Drug Targets 8(4), 243-252 (2008) (Pubitemid 351881350)
20. G. Zadeh, A. Guha, Neoangiogenesis in human astrocytomas: expression and functional role of angiopoietins and their cognate receptors. Front. Biosci. 8, e128-e137 (2003)
21. Wang H.L., Deng C.S., J. Lin, Pan D.Y., Zou Z.Y., Zhou X.Y., Expression of angiopoietin-2 is correlated with vascularization and tumor size in human colorectal adenocarcinoma. Tohoku J. Exp. Med. 213(1), 33-40 (2007) (Pubitemid 47516899)
22. S. Nag, N. Nourhaghighi, R. Venugopalan, Asa S.L., Stewart D.J., Angiopoietins are expressed in the normal rat pituitary gland. Endocr. Pathol. 16(1), 67-73 (2005) (Pubitemid 41278317)
23. B. Hu, P. Guo, Q. Fang, Tao H.Q., D. Wang, M. Nagane, Huang H.J., Y. Gunji, R. Nishikawa, K. Alitalo et al., Angiopoietin-2 induces human glioma invasion through the activation of matrix metalloprotease-2. Proc. Natl. Acad. Sci. USA 100(15), 8904-8909 (2003) (Pubitemid 36899196)
24. Haqqani A.S., Sandhu J.K., Birnboim H.C., Expression of interleukin- 8 promotes neutrophil infiltration and genetic instability in mutatect tumors. Neoplasia 2(6), 561-568 (2000) (Pubitemid 32098691)
25. Bischoff D.S., Zhu J.H., Makhijani N.S., A. Kumar, Yamaguchi D.T., Angiogenic CXC chemokine expression during differentiation of human mesenchymal stem cells towards the osteoblastic lineage. J. Cell. Biochem. 103(3), 812-824 (2008) (Pubitemid 351240617)
26. K. Xie, Interleukin-8 and human cancer biology. Cytokine Growth Factor Rev. 12(4), 375-391 (2001) (Pubitemid 32851749)
27. Green V.L., Atkin S.L., V. Speirs, Jeffreys R.V., Landolt A.M., B. Mathew, L. Hipkin, White M.C., Cytokine expression in human anterior pituitary adenomas. Clin. Endocrinol. (Oxf.) 45(2), 179-185 (1996) (Pubitemid 26278311)
28. Suliman M.E., Royds J.A., L. Baxter, Timperley W.R., Cullen D.R., Jones T.H., IL-8 mRNA expression by in situ hybridisation in human pituitary adenomas. Eur. J. Endocrinol. 140(2), 155-158 (1999) (Pubitemid 29090444)
29. Jang T.J., Ji Y.S., Jung K.H., Decreased expression of 15-hydroxyprostaglandin dehydrogenase in gastric carcinomas. Yonsei Med. J. 49(6), 917-922 (2008)
30. Coggins K.G., A. Latour, Nguyen M.S., L. Audoly, Coffman T.M., Koller B.H., Metabolism of PGE2 by prostaglandin dehydrogenase is essential for remodeling the ductus arteriosus. Nat. Med. 8(2), 91-92 (2002) (Pubitemid 34155104)
31. I. Wolf, J. O'Kelly, T. Rubinek, M. Tong, A. Nguyen, Lin B.T., Tai H.H., Karlan B.Y., Koeffler H.P., 15-Hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer. Cancer Res. 66(15), 7818-7823 (2006) (Pubitemid 44289243)
32. Yee K.S., Yu V.C., Isolation and characterization of a novel member of the neural zinc finger factor/myelin transcription factor family with transcriptional repression activity. J. Biol. Chem. 273(9), 5366-5374 (1998) (Pubitemid 28108705)
33. Y. Jiang, Yu V.C., F. Buchholz, S. O'Connell, Rhodes S.J., C. Candeloro, Xia Y.R., Lusis A.J., Rosenfeld M.G., A novel family of Cys-Cys, His-Cys zinc finger transcription factors expressed in developing nervous system and pituitary gland. J. Biol. Chem. 271(18), 10723-10730 (1996) (Pubitemid 26145809)
34. J. Yang, Siqueira M.F., Y. Behl, M. Alikhani, Graves D.T., The transcription factor ST18 regulates proapoptotic and proinflammatory gene expression in fibroblasts. FASEB J. 22(11), 3956-3967 (2008)
35. B. Jandrig, S. Seitz, B. Hinzmann, W. Arnold, B. Micheel, K. Koelble, R. Siebert, A. Schwartz, K. Ruecker, Schlag P.M. et al., ST18 is a breast cancer tumor suppressor gene at human chromosome 8q11.2. Oncogene 23(57), 9295-9302 (2004) (Pubitemid 40069700)
36. Elston M.S., Gill A.J., Conaglen J.V., A. Clarkson, Shaw J.M., Law A.J., Cook R.J., Little N.S., Clifton R.J.-Bligh, Robinson B.G. et al., Wnt pathway inhibitors are strongly down-regulated in pituitary tumors. Endocrinology 149(3), 1235-1242 (2008) (Pubitemid 351397935)
37. A. Subramanian, P. Tamayo, Mootha V.K., S. Mukherjee, Ebert B.L., Gillette M.A., A. Paulovich, Pomeroy S.L., Golub T.R., Lander E.S. et al., Gene set enrichment analysis: a knowledgebased approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102(43), 15545-15550 (2005) (Pubitemid 41528093)
38. B. Vogelstein, D. Lane, Levine A.J., Surfing the p53 network. Nature 408(6810), 307-310 (2000)
39. S. Jin, Levine A.J., The p53 functional circuit. J. Cell Sci. 114(Pt 23), 4139-4140 (2001) (Pubitemid 33138651)
40. M. Gasco, S. Shami, T. Crook, The p53 pathway in breast cancer. Breast Cancer Res. 4(2), 70-76 (2002) (Pubitemid 34248123)
41. J. Ying, G. Srivastava, Hsieh W.S., Z. Gao, P. Murray, Liao S.K., R. Ambinder, Q. Tao, The stress-responsive gene GADD45G is a functional tumor suppressor, with its response to environmental stresses frequently disrupted epigenetically in multiple tumors. Clin. Cancer Res. 11(18), 6442-6449 (2005) (Pubitemid 41338980)
42. R. Ohki, J. Nemoto, H. Murasawa, E. Oda, J. Inazawa, N. Tanaka, T. Taniguchi, Reprimo, a new candidate mediator of the p53-mediated cell cycle arrest at the G2 phase. J. Biol. Chem. 275(30), 22627-22630 (2000) (Pubitemid 30646143)
43. S. Kapoor, Altered expression of the PMAIP1 gene: a major player in the evolution of gastrointestinal and systemic malignancies. Dig. Dis. Sci. 53(10), 2834-2835 (2008)
44. F. Ruf, Fink M.Y., Sealfon S.C., Structure of the GnRH receptorstimulated signaling network: insights from genomics. Front. Neuroendocrinol. 24(3), 181-199 (2003) (Pubitemid 37329471)
45. Bedecarrats G.Y., Kaiser U.B., Mutations in the human gonadotropin- releasing hormone receptor: insights into receptor biology and function. Semin. Reprod. Med. 25(5), 368-378 (2007) (Pubitemid 47342404)
46. Million P.C., White C.R., King M.W., Quirk P.L., Iovanna J.L., Quirk C.C., Loss of the protein NUPR1 (p8) leads to delayed LHB expression, delayed ovarian maturation, and testicular development of a sertoli-cell-only syndrome-like phenotype in mice. Biol. Reprod. 79(4), 598-607 (2008)
47. Burns K.H., Matzuk M.M., Minireview: genetic models for the study of gonadotropin actions. Endocrinology 143(8), 2823-2835 (2002) (Pubitemid 34809852)